Public Health Update
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice
LOGIN / REGISTER
Public Health Update
SUBSCRIBE
Public Health Update
Public Health Update
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice

All Right Reserved. Designed and Developed by PenciDesign

Fifth Global Forum on Human Resources for Health
ConferenceHuman Resource for HealthPublic Health EventsPublic Health OpportunitiesPublic Health Opportunity

Fifth Global Forum on Human Resources for Health

by Public Health Update March 17, 2023
written by Public Health Update

The Fifth Global Forum on Human Resources for Health will be held from 3 to 5 April 2023, during World Health Worker Week.

The Forum will be held under the theme of Protecting, safeguarding, and investing in the health and care workforce. Marking more than five years since the adoption of the Global Strategy on Human Resources for Health: Workforce 2030, the Forum will provide updates on progress in its implementation and share evidence and experiences on workforce development, as well as opportunities for a post COVID-19 era that will inform the implementation of the Working for Health 2022-2030 Action Plan. It will examine the required policy solutions, investments, and multi-sectoral partnerships to address health and care workforce challenges and advance health systems towards universal health coverage and health security. The outcomes of the Forum will inform the United Nations General Assembly’s High-Level Meeting on UHC in September 2023.

The Forum is intersectoral and will engage participation from a range of actors, including high-impact decision-makers, across education, finance, gender, health, labour/employment, and migration sectors. The format will be hybrid. In person participation will be for speakers participating in the high-level roundtable dialogue. Parallel sessions and other learning and networking activities will be held virtually and available upon registration through an IT platform dedicated for the Forum. The language of the Forum will be English with simultaneous interpretation available for the high-level roundtables.

Purpose

  • To share progress on the implementation of the Global Strategy on HRH: workforce 2030, and the SDG agenda
  • To examine the required policy options and investments to address global health and care workforce challenges and build capacities and capabilities to advance health systems towards UHC and global health security
  • To identify opportunities for countries of all income classification to develop and align intersectoral activities, engaging relevant partners and stakeholders as needed.

Expected outcomes

  • Drive national multi-sectoral political engagement to address workforce challenges for UHC and the essential public health functions, including Emergency preparedness and response
  • Develop consensus on priority workforce solutions to inform preparations for United Nations High-Level Meeting on Universal Health Coverage (September 2023)
  • Inform and influence domestic and international investments in education and jobs 
  • Launch of the Multi-sectoral advisory group of experts (MSAGE)

Registration Link


  • National Human Resources for Health (HRH) Strategy 2021-2030, Nepal
March 17, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Five cities recognized for public health achievements at Partnership for Healthy Cities Summit
Global Health NewsNational Health NewsOutbreak NewsPublic HealthPublic Health NewsPublic Health UpdateWorld News

Five cities recognized for public health achievements at Partnership for Healthy Cities Summit

by Public Health Update March 16, 2023
written by Public Health Update

Partnership for Healthy Cities award recipients include Montevideo, Uruguay for food policy; Mexico City, Mexico for road safety; Vancouver, Canada for surveillance; Athens, Greece for overdose prevention, and Bengaluru, India for tobacco control.

The first-of-its-kind Summit was convened in London by Bloomberg Philanthropies, World Health Organization, Vital Strategies, and Mayor Sadiq Khan of London.

During the inaugural Partnership for Healthy Cities Summit in London, five global cities were recognized for their achievements in preventing noncommunicable diseases (NCDs) and injuries. The Summit brought together mayors and officials from more than 50 major cities in the partnership to discuss urgent public health concerns and best practices that save lives and create healthier cities.

With the majority of the global population now living in urban settings, ensuring the health and wellbeing of residents in our world’s urban centers is crucial. NCDs – including heart disease, stroke, cancer, diabetes, and chronic respiratory diseases – and injuries are responsible for over 80% of all deaths globally. Cities are uniquely positioned to transform the fight against NCDs and injuries by implementing policies to significantly reduce exposure to risk factors. The Summit highlights best practices and proven interventions, which is especially important as public health is at risk of becoming less of a priority three years after the start of the COVID-19 pandemic.

“Noncommunicable diseases and injuries pose the number-one threat to global public health. Mayors worldwide are increasingly uniting to confront it, and the Partnership for Healthy Cities will continue to support their urgent and lifesaving work,” said Michael R. Bloomberg, founder of Bloomberg LP and Bloomberg Philanthropies, 108th mayor of New York City, and WHO Global Ambassador for Noncommunicable Diseases and Injuries. “Our network’s first-ever Summit showcased the best of local public health leadership, and given the gains achieved by our inaugural award winners, we expect even more leaders will follow in their footsteps as they create healthier, more vibrant cities.”

“The five cities being recognized today demonstrate that mayors can drive powerful progress to protect the health of their citizens,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “WHO remains committed to working through the Partnership for Healthy Cities to support mayors around the world to build cities that promote and protect health, rather than harm it.” 

Founded in 2017, the Partnership for Healthy Cities is a prestigious global network comprised of 70 cities working together to prevent NCDs and injuries. Mayors in the partnership were invited to join and committed to addressing a pressing public health issue in their city. Supported by Bloomberg Philanthropies in partnership with the WHO and Vital Strategies, this initiative enables cities around the world to deliver a high-impact policy or programmatic intervention to reduce NCDs and injuries in their communities. Through the Partnership for Healthy Cities, local leaders around the world have enacted policies that are improving the health and safety of millions of people.

During the Summit, five member cities were recognized with a 2023 Partnership for Healthy Cities Award for positively impacting the health of their population and making sustainable and lasting strides toward NCD and injury prevention that can be replicated in other jurisdictions. 

The five winning cities, each receiving US$ 150 000 to further their work with the partnership, are:

  • Athens, Greece for increasing access to the opioid overdose reversal agent, naloxone, at community-based organizations and among healthcare professionals. The city also started researching causes of death among people who inject drugs to better understand the impact of the overdose crisis;
  • Bengaluru, India for their efforts in tobacco control, specifically, reducing smoking in public places and improving compliance with existing mandates on public smoking bans;
  • Mexico City, Mexico for improving road safety and safe and active mobility by launching a bike path on a busy road that led to a 275% increase in cyclists; implementing a shared lane for cyclists and buses separate from cars; establishing loading and unloading areas; and optimizing design and management of roads close to schools;
  • Montevideo, Uruguay for establishing nutritional standards for the preparation and sale of food in government agency offices and some public universities, for focusing on sodium reduction policies and developing media campaigns and educational materials; and 
  • Vancouver, Canada for making public health data more inclusive and accessible by launching an online public health data tool that tracks population health indicators and working with urban Indigenous communities to better inform data management.  

“These initiatives are not only improving the health of Londoners, but alleviating pressure off our health service and ensuring that future generations can thrive. Improving the health of Londoners will always be at the heart of my vision to build a safer and more prosperous London for everyone.”said the Mayor of London, Sadiq Khan“I’m delighted to be joining Mayors from around the world today to tackle some of the biggest issues facing our cities. The health of our citizens is a city’s greatest asset so I’m taking bold steps to invest in the health of Londoners, such as restricting junk food advertising across the Transport for London network and expanding the Ultra Low Emission Zone, which will mean five million more Londoners will be able to breathe cleaner air.”

“Cities are places where health can be produced or compromised,” said José Luis Castro, President and CEO, Vital Strategies. “We applaud the work of urban leaders around the globe in their efforts to create healthier, stronger and more equitable cities. We are eager to continue our work supporting cities with the tools and resources needed to bring proven solutions that prevent noncommunicable diseases and injuries to fruition.”

The mayors who attended the inaugural Partnership for Healthy Cities Summit—and their city’s public health focus areas—are:

  • Mayor Kiritkumar Jivanlal Parmar, Ahmedabad, India
    Focus area: Noncommunicable disease surveillance
  • Mayor Kostas Bakoyannis, Athens, Greece
    Focus area: Overdose prevention 
  • Mayor José Sarto, Fortaleza, Brazil
    Focus area: Improving air quality surveillance 
  • Mayor Erias Lukwago, Kampala, Uganda
    Focus area: Improving air quality surveillance 
  • Mayor Balendra Shah, Kathmandu, Nepal
    Focus area: Improving air quality surveillance
  • Mayor Samuel Pyne, Kumasi, Ghana
    Focus area: Reducing traffic fatalities through speed management      
  • Mayor Sadiq Khan, London, United Kingdom
    Focus area: Reducing children’s exposure to unhealthy food and drink through advertising restrictions
  • Mayor Chilando Chitangala, Lusaka, Zambia
    Focus area: Reducing road traffic injuries, with a special focus on women and children 
  • Mayor Carolina Cosse, Montevideo, Uruguay
    Focus area: Nutrition standards
  • Mayor Joy Belmonte, Quezon City, Philippines
    Focus area: Pursuing healthier restaurant environments, with a focus on calorie labeling on menus
  • Governor Claudio Orrego Larraín, Santiago, Chile
    Focus area: Developing a metropolitan mobility policy  
  • Mayor Carolina Mejía, Santo Domingo, Dominican Republic
    Focus area: Speed management on urban avenues                                            
  • Mayor Se-hoon Oh, Seoul, South Korea
    Focus area: Improving adherence with tobacco advertising restrictions in public areas   

15 March 2023 News release WHO

March 16, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
WHO health workforce support and safeguards list 2023
Health SystemsHuman Resource for HealthPublic HealthPublic Health Update

WHO renews alert on safeguards for health worker recruitment

by Public Health Update March 16, 2023
written by Public Health Update

The World Health Organization (WHO) released an updated WHO health workforce support and safeguards list 2023, identifying 55 countries as vulnerable for availability of health workers required to achieve the UN Sustainable Development Goal target for universal health coverage (UHC) by 2030.

The impact of COVID-19 and widespread disruptions to health services has resulted in a rapid acceleration in the international recruitment of health workers. For countries losing health personnel to international migration, this could negatively impact on health systems and hinder their progress towards achieving UHC and health security.

Of the 55 countries, 37 are in the WHO African region, eight in the Western Pacific region, six in the Eastern Mediterranean region, three in the South-East Asia region (Inc. Nepal) and one is in the Americas. Eight countries have been newly added to the WHO health workforce support and safeguards list 2023 since its original publication in 2020.

“Health workers are the backbone of every health system, and yet 55 countries with some of the world’s most fragile health systems do not have enough and many are losing their health workers to international migration,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “WHO is working with these countries to support them to strengthen their health workforce, and we call on all countries to respect the provisions in the WHO health workforce support and safeguards list.”  The list should be used to inform advocacy, policy dialogue at all levels and financing efforts in support of health workforce education and employment in these countries.

The countries included in the WHO health workforce support and safeguards list 2023 have a UHC service coverage index below 55 and health workforce density below the global median: 49 medical doctors, nursing and midwifery personnel per 10 000 people. These countries require priority support for health workforce development and health system strengthening, along with additional safeguards that limit active international recruitment.

The WHO health workforce support and safeguard list 2023 does not prohibit international recruitment, but recommends that government-to-government health worker migration agreements:

  • be informed by health labour market analysis and the adoption of measures to ensure adequate supply of health workers in the source countries;
  • engage Ministries of Health in the negotiation and implementation of agreements; and
  • specify the health system benefits of the arrangement to both source and destination countries.

WHO also recommends that these safeguards be extended to all low- and middle-income countries.

Implementation of the WHO Global code of practice on the international recruitment of health personnel (WHO Global Code) can ensure that international movement of health workers is ethically managed, supports the rights and welfare of migrant health workers and maintains health service delivery objectives.

The 2023 update is informed by the report of the WHO Expert Advisory Group on the Relevance and Effectiveness of the WHO Global Code. WHO will update the list every three years, with the next update scheduled for publication in 2026.

This issue will be discussed at the upcoming Fifth Global Forum on Human Resources for Health, which will examine the required policy solutions, investments, and multi-sectoral partnerships to address health and care workforce challenges to advance health systems towards the attainment of UHC and health security. The outcomes of the Forum will inform the United Nations General Assembly’s High-Level Meeting on UHC in September 2023.

 WHO health workforce support and safeguards list 2023

WHO 14 March 2023  News release Geneva, Switzerland 

March 16, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Consolidated Guidelines for malaria
Global Health NewsPublic Health NewsPublic Health UpdateVector-Borne Diseases(VBDs)World News

WHO publishes recommendations on two new types of insecticide-treated nets

by Public Health Update March 14, 2023
written by Public Health Update

Since 2005, over 2 billion insecticide-treated nets (ITNs) have been distributed worldwide to prevent malaria. All of these nets were treated with only one insecticide class – pyrethroids. However, as mosquitoes in many areas are now resistant to pyrethroids, nets treated with other active ingredients are needed to control malaria.

In 2017, WHO started to recommend a new type of ITN that combines pyrethroids with piperonyl-butoxide (PBO), a chemical that enhances the potency of pyrethroids against resistant mosquitoes.

New recommendations, published today in the WHO Guidelines for malaria, cover 2 new classes of dual ingredient ITNs with different modes of action:

  • Pyrethroid-chlorfenapyr nets combine a pyrethroid and a pyrrole insecticide to enhance the killing effect of the net.
  • Pyrethroid-pyriproxyfen nets combine a pyrethroid with an insect growth regulator (IGR). The IGR disrupts mosquito growth and reproduction.

New recommendation on pyrethroid-chlorfenapyr nets vs pyrethroid-only nets

WHO is issuing a strong recommendation for the deployment of pyrethroid-chlorfenapyr ITNs vs pyrethroid-only nets to prevent malaria in adults and children in areas where mosquitoes have become resistant to pyrethroids.

The recommendation considers that, compared to pyrethroid-only nets or pyrethroid-PBO nets, pyrethroid-chlorfenapyr ITNs should have an increased killing effect against pyrethroid-resistant malaria vectors and, thus, a greater impact against malaria.

New recommendation on pyrethroid-chlorfenapyr nets vs pyrethroid-PBO nets

WHO is issuing a conditional recommendation for the deployment of pyrethroid-chlorfenapyr ITNs instead of pyrethroid-PBO nets to prevent malaria in adults and children in areas with pyrethroid resistance.

The conditionality of the recommendation is based on the judgement of the WHO Guidelines Review Group (GDG) that the balance of desirable and undesirable effects probably favours pyrethroid-chlorfenapyr nets over pyrethroid-PBO nets. The recommendation is based on evidence drawn from only one trial in Africa.

New recommendation on pyrethroid-pyriproxyfen nets vs pyrethroid-only nets

WHO is issuing a conditional recommendation for the deployment of pyrethroid-pyriproxyfen nets instead of pyrethroid-only nets to prevent malaria in adults and children in areas with pyrethroid resistance.

The conditionality of the recommendation is based on the GDG’s concerns around the poor cost-effectiveness of pyrethroid-pyriproxyfen nets compared to pyrethroid-only nets; the extra resources currently required to purchase these ITNs may have a negative impact on coverage and equity.

New recommendation on pyrethroid-pyriproxyfen nets vs pyrethroid-PBO nets

WHO has issued a conditional recommendation against the deployment of pyrethroid-pyriproxyfen nets instead of pyrethroid-PBO nets.

The conditionality of the recommendation is based on the GDG’s judgement that the balance of effects favours pyrethroid-PBO nets over pyrethroid-pyriproxyfen nets and that, based on current cost and efficacy data, pyrethroid-PBO nets are more cost-effective.

Assessing the quality of a body of evidence

In 2007, WHO adopted GRADE (Grading of Recommendations Assessment, Development and Evaluation) as the method for assessing the quality of a body of evidence and for determining the direction and strength of the resulting recommendations. GRADE categorizes the quality of evidence as high, moderate, low or very low. GRADE assessments are determined through the consideration of several factors, including risk of bias, inconsistency, indirectness, imprecision and publication bias. All of the recommendations published today are based on a moderate certainty of evidence.

New guidance on ITN prioritization in resource-constrained settings

Together with the new recommendations, WHO is publishing new guidance to support national malaria programmes in decisions on which nets to prioritize in resource-limited settings.

This guidance focuses, as a first step, on ensuring coverage of ITNs for vulnerable groups – particularly pregnant women and children under the age of 5 – and then on planning for high-volume net distribution campaigns. While the guidance is based on best practices generated in Africa in recent years, it can be used as a component of prioritization processes by all countries deploying ITNs.

Threats to ITNs – a critical malaria prevention tool

Over the last 2 decades, ITNs have contributed significantly to the progress seen in reducing malaria cases worldwide. A 2015 modelling analysis published in Nature suggested that ITNs drove most of the declines in malaria seen from 2005–2015, especially in moderate-to-high transmission areas. However, progress since 2015 has slowed.

According to WHO’s latest World malaria report, the emergence and wide geographic spread of pyrethroid resistance among malaria-transmitting mosquitoes is the most recognized threat to the effectiveness of ITNs.

Other threats to this key prevention tool include insufficient coverage and access; challenges relating to the physical and chemical durability of nets; and changing behaviour of mosquitoes, which appear to be biting early before people go to bed and resting outdoors, thereby evading exposure to insecticides.

READ MORE: OFFICIAL LINK (WHO, 14 March 2023)


WHO Guidelines for malaria

WHO regularly convenes the world’s leading malaria experts to review available evidence and advise on recommendations to control and eliminate malaria. The consolidated Guidelines for malaria, launched in February 2021, bring together – for the first time – all of the Organization’s current recommendations for malaria in one user-friendly online resource. Through the MAGICapp platform you will find:

  • All WHO evidence-based recommendations for malaria prevention (vector control and preventive chemotherapies) and case management (diagnosis and treatment) and elimination.
  • Links to other resources, such as guidance and information on the strategic use of information to drive impact; surveillance, monitoring and evaluation; operational manuals, handbooks, and frameworks; and a glossary of terms and definitions.

These consolidated guidelines replace 2 guideline documents on the WHO website: the Guidelines for the treatment of malaria, third edition and the Guidelines for malaria vector control. As new evidence becomes available, the recommendations will be reviewed and updated, where appropriate, using WHO’s transparent and rigorous guideline development process.

Clear, evidence-informed recommendations are designed to guide countries as they develop national malaria strategic plans; they support decisions around “what to do”. WHO also develops implementation guidance such as operational and field manuals to advise countries on “how to” deliver the recommended tools and strategies.

The consolidation of WHO’s malaria guidelines is one of a number of actions the Organization has undertaken in recent years to make its guidance more accessible to end users in malaria-endemic countries. The overall aim is to deliver timely, high quality recommendations through processes that are more transparent, consistent, efficient and predictable.

DOWNLOAD GUIDELINE

March 14, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Watchers to participate in the 76th World Health Assembly
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

Call for Watchers to participate in the 76th World Health Assembly

by Public Health Update March 12, 2023
written by Public Health Update

PHM is preparing to watch the 76th World Health Assembly (WHA76) of the World Health Organisation. The session will take place from 21st to 30th May in Geneva, Switzerland. The World Health Assembly takes place once and the Executive Board meeting takes place twice a year. The items on the WHA76 agenda will likely include Public Health Emergencies: preparedness and response (including health emergency in Ukraine), Implementation of International Health Regulations (2005), Prevention and Control of  Non Communicable Diseases,  UNGA high-level meetings preparation for Universal Health Coverage resolution and a declaration for NCD and mental health, Influenza Preparedness, Polio Eradication Transition, and WHO’s sustainable financing.

Can you attend the WHO-Watch for the WHA75 Meeting?

Through Medicus Mundi International, PHM participants, or Watchers, are able to attend the meeting, work on PHM’s commentaries, collaborate with civil society colleagues,  advocate our position to the WHO and country delegates, and deliver statements from the floor to the governing body meeting. We are looking for young PHM activists to join as Watchers in Geneva. If you are keen on developing your knowledge on issues discussed at the meeting, and to be involved in strengthening these issues in your country or region after the meeting, please let us know. As the work is intense, being able to work under pressure while still providing support to your fellow Watchers is what we are looking for. We expect the Watchers to prioritize the watching work and be available for the full period of the meetings, including a preparatory in-person workshop the week before the WHA76. This means arriving on Sunday 14th May 2023 and departing on 30th May 2023.

If you are interested in the politics of global health governance and understanding the role that people’s movements can play in UN processes, the preparatory workshop will be of interest for you. It will also help the you acquaint yourself with the agenda topics and work on them. The workshop will be held from 15th to 20th May in Geneva.

To participate in the WHA76 watch please fill out the application form below. The deadline to fill the form is 17th March, 2023. Note a small number of watchers (1 or 2) will be chosen for representing each region due to the team being small (12-14). Meetings and sessions will be held in English so participants must be fluent English speakers.

In case you have any query, please contact: Lauren Paremoer (lauren@phmovement.org ) OR Candelaria Aráoz Falcón (candelaria@phmovement.org).

Click here for the application form
March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Experts
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesNoticePublic Health OpportunitiesPublic Health Opportunity

Open Call: WHO Academy Quality Committee

by Public Health Update March 12, 2023
written by Public Health Update

The World Health Organization (WHO) is seeking experts to serve as members of the WHO Academy Quality Committee to fill open positions from the South-East Asia Region (SEARO) and African Region (AFRO). This “Call for experts” provides information about the WHO Quality Committee, the expert profile being sought, the process to express interest, and the process of selection.

Background

Established in 2019, The WHO Academy is a priority initiative of the WHO transformation agenda and will support accelerated learning towards achievement of existing global public health goals supported by the United Nations and the WHO. The Academy will support the competency development needs of WHO staff and stakeholders with innovative digital and state-of-the-art in-person learning experiences. Academy courses will be accessible through its digital learning experience platform and via its campus network. The Academy’s Campus in Lyon, France, will feature high-tech learning environments, a world-class health emergency simulation centre and collaboration spaces for learning co-design, research and innovation for health impact.

The Academy will be officially launched in early 2024 as an internal WHO Department. The Academy Quality Committee has been established to serve in an advisory capacity to the WHO with a focus on providing expert and strategic advice and recommendations to support WHO in its implementation of world class standards and quality management system with the WHO Academy and the Health Workforce Department.

Functions of the WHO Academy Quality Committee

The Quality Committee will undertake the following key functions:

a. Review and make recommendations on the development and evolution of the Academy’s standards, quality management system and metrics to ensure alignment with best practice, evidence and international standards in lifelong learning

b. Provide strategic recommendations, best practices and insights on lifelong learning systems and technologies that will enhance the Academy’s quality efforts in delivering its programs and services

c. Provide guidance and recommendations on quality frameworks that ensure adaptability in the marketplace given the rapid evolution of skills acquisition and competency based lifelong learning

Operations of the Academy Quality Committee

The Quality Committee shall have up to 9 members, who shall serve in their personal capacities to represent the broad range of disciplines relevant to the work of the WHO Academy. The Quality Committee shall normally meet two times each year. However, WHO may convene additional meetings. The Quality Committee meetings may be held in person (at WHO headquarters in Geneva, WHO Academy Campus in Lyon or another location, as determined by WHO) or virtually, via video or teleconference. The working language of the group will be English.

Who can express interest?

The WHO Academy Quality Committee will be diverse and multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to quality assurance, adult learning, credentialing, innovative learning technologies, and learning science. The WHO is seeking one member from the SEARO region and one member from the AFRO region. Eligible members include those individuals whose nationality and significant work experience has been conducted in countries represented by

  • SEARO: Bangladesh, Bhutan, Democratic People’s Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste,
  • AFRO: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cabo Verde, Cameroon, Central African Republic, Chad, Comoros, Congo, Cote d’Ivoire, Democratic Republic of Congo, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, South Africa, South Sudan, Togo, Uganda, United Republic of Tanzania, Zambia, Zimbabwe

WHO welcomes expressions of interest from:

a. internationally renowned experts with an outstanding record of achievement, credibility and be recognized as regional thought leaders in their field relevant to the Quality Committee

b. Have diverse experience and expertise in one or more of the following areas: quality assurance, adult learning, credentialing, innovative learning technologies, and learning science

c. Have proven experience of operating at the highest strategic level in the public, private or other sectors

d. Have excellent interpersonal and communication skills to support effective discussion with a range of stakeholders

e. Subscribe to the values and ethical code of WHO

Submitting your expression of interest

To register your interest in being considered for the WHO Academy Quality Committee, please submit the following documents by 19 March 2023, 24:00h (midnight) Geneva time to https://whoacademy.awardsplatform.com/

  • A cover letter, indicating your motivation to apply, your relevant regional and global affiliations and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer;
  • Your curriculum vitae; and
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed.

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, the proposed member will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of an AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents. WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing AG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to academy@who.int well before the applicable deadline.

Deadline: March 19, 2023, 24:00h (midnight) Geneva time.

Official Link

March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Experts
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesMaternal, Newborn and Child HealthPublic Health OpportunitiesPublic Health Opportunity

Call for experts – Mother and Newborn Information for Tracking Outcomes and Results (MoNITOR) Advisory Group

by Public Health Update March 12, 2023
written by Public Health Update

The Mother and Newborn Information for Tracking Outcomes and Results (MoNITOR) Advisory Group (AG) was established by WHO in 2016 to act as an advisory body on matters of measurement, metrics and monitoring of maternal and newborn health. MoNITOR AG’s core function is to provide recommendations to WHO on harmonized guidance, messages, and tools so that countries can collect useful data to track progress toward achieving the Sustainable Development Goals through
1) providing independent advice to WHO on monitoring-related guidance and norms and data collection platforms;
2) convening maternal and newborn measurement initiatives to avoid duplication and coordinate messages to national and international communities; and
3) prioritizing metrics-related research priorities and capacity building. MoNITOR AG meets twice per year and has convened a total of 11 meetings to date. 
Read more

Requirements and Application Process

Members of the MONITOR AG must have strong technical knowledge including but not restricted to: 

  • Methodologies for generating information, including health information systems, health facility surveys, household surveys, and demographic surveillance systems
  • Past experience in normative working groups of a technical nature
  • Tracking progress towards reducing maternal and neonatal mortality and morbidity
  • Monitoring and evaluation capacity development
  • Health information systems implementation
  • Monitoring economic and financial indicators
  • Expertise in maternal, newborn, nutrition, and health system monitoring and measurement

 Attendance at meetings is mandatory for all advisory group members.

Interested candidates should submit:

  • A brief curriculum vitae (2-3 pages)
  • A list of authored papers to demonstrate area(s) of expertise and how he/she has contributed to the field of measurement
  • One example of a work product or report
  • A short statement discussing their measurement challenge priority in maternal and newborn health (200 words maximum)

The WHO Secretariat will review the nominations and identify up to 18 proposed members, considering:

  • Gender balance
  • Geographic balance
  • Technical expertise with regards to metrics research, epidemiology, monitoring and evaluation of maternal and newborn indicators/health.

The WHO Secretariat will contact all selected members with information on the next MoNITOR meeting, which is anticipated for 6 to 8 June 2023 in Geneva, Switzerland. 

Each proposed member will be required to complete a WHO declaration of interest (DOI) form, and his/her appointment will be subject to:

  • the WHO Secretariat having evaluated the completed declaration of conflict of interest form, and determining that his/her participation would not give rise to a real, potential or apparent conflict of interest; and
  • counter-signature by the proposed member of WHO’s invitation letter and accompanying Memorandum of Agreement, Terms and Conditions for Temporary Advisers.
  • Candidates who are not nominated will be informed.
  • Duration of term of appointment: May 2023 – April 2026.

All nomination submissions should be sent to monitor@who.int labelled “MoNITOR Advisory Closing date for submission: 31 March 2023.

Official Link

March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Experts
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

Call for applications to support the finalization of the WHO Abortion Care Monitoring and Evaluation Framework

by Public Health Update March 12, 2023
written by Public Health Update

Purpose of the APW

WHO seeks a qualified supplier with expert knowledge of abortion care monitoring and evaluation, to support the finalization of the WHO Abortion Care Guideline Monitoring and Evaluation framework text and supporting materials, including Abortion Care Monitoring and Evaluation Conceptual Framework, Indicator library with metadata, and Support for country-specific abortion care monitoring and evaluation. The APW is proposed for a duration from 27 March 2023 to 15 December 2023. 

Background

The World Health Organization’s Department of Sexual and Reproductive Health and Research (SRH) includes the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP). Located in Geneva, HRP is the main instrument within the United Nations system for identifying research priorities on sexual and reproductive health and rights; for promoting, conducting, evaluating and coordinating related interdisciplinary research; for collaborating with countries to build national capacity to conduct research; and for promoting the use of research results in policy making and sexual and reproductive health programmes. The Department draws on research and global expertise to set norms and standards and develop global guidelines on sexual and reproductive health and rights. More information about SRH and HRP.

The Prevention of Unsafe Abortion Unit (PUA) is responsible for research and development, innovation, evidence synthesis, development of guidance and implementation tools, provision of specialized technical support, and dissemination of information on evidence-based practices on prevention of unsafe abortion, including safe and quality abortion services and post-abortion care. 

WHO/HRP is currently developing the Abortion Care Guideline Monitoring and Evaluation framework and indicators, a derivative product of the new Abortion Care Guideline (2022), to update the Monitoring, Evaluation and Quality Improvement Guidance from the Safe Abortion: Technical and Policy Guidance (2012). 

In addition to aligning with the Abortion Care Guideline, updated Abortion Care Guideline Monitoring and Evaluation materials will align with the WHO and UNICEF Primary Health Care Measurement Framework and Indicators (2022). The M&E guidance will build on HRP’s existing abortion M&E portfolio.

Work to be performed

Objectives:

  • Prepare Abortion Care Guideline Monitoring and Evaluation framework and supporting materials for initial and final expert review on-line meetings 
  • Prepare Abortion Care Guideline Monitoring and Evaluation framework and supporting materials for final expert document review 
  • Finalize Abortion Care Guideline Monitoring and Evaluation framework and supporting materials by responding to expert comments and recommendations 
  • Support organization and implementation of expert review meetings and expert document review 

Expected outputs: 

  • Finalized WHO Abortion Care Guideline Monitoring and Evaluation framework text and supporting materials for publication 

Specific requirements 

Qualifications required: 

  • Qualification in public health, demography, epidemiology, social sciences, or related field.  
  • Extensive experience in sexual and reproductive health, specifically abortion, monitoring and evaluation
    • Experience monitoring and evaluation abortion programs in low- and/or middle-income countries, including development of monitoring and evaluation plans, implementing evaluation activities, analysing and reporting monitoring and evaluation data;  
    • Experience in qualitative and quantitative indicator development, testing and implementation,  
    • Experience in metadata development, including indicator-specific instructions for data analysis and output 
  • Familiarity with WHO tools and guidelines on abortion care.  
  • Demonstrated skills in coordinating with multiple stakeholders in an international environment;  
  • Being adept at working in a fast-paced environment, working with multiple teams   
  • Excellent writing and oral communication skills in English; knowledge of other UN official languages is desirable 
  • Strong planning and organizational capability, demonstrated ability to manage converging priorities and deliver high-quality products under tight deadlines. 
  • Ability to establish and maintain good working relations with counterparts, and with the international constituency with which the project relates.   

Place of assignment 

Support will be provided remotely at a location at the discretion of the service provider. 

Travel 

No travel is expected. 

Application Process 

Applicants should submit a cover letter and CV by 15 March 2023 to: srhpua@who.int. 

Applications received after this date will not be accepted. In the email subject line, please put “Abortion Care Guideline Monitoring and Evaluation Framework and Indicators”.   Only candidates under serious consideration will be contacted. 

Deadline for application: 15 March 2023 at 18:00 Geneva Switzerland time (CET)

Official Link

March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Call for Experts
Call for Proposal, EOI & RFPEnvironmental Health & Climate ChangeInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

Call for Experts: WHO Technical Advisory Group on Economics for Environment, Climate Change and Health

by Public Health Update March 12, 2023
written by Public Health Update

The World Health Organization (WHO) is seeking experts to serve as members one of the WHO Technical Advisory Group on Economics for Environment, Climate Change and Health. This “Call for experts” provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

Background

Exposure to environmental, climatic and occupational risk factors causes an estimated 13.3 million deaths globally each year. The economic recovery from the ongoing crises of the Covid-19 pandemic, violent conflicts, environmental pollution and anthropogenic climate change must be healthy, green and fair. Countries, sub-national governments and international organizations are making significant efforts to reduce environmental pollution, curb climate change, ensure decent work, and design economic stimuli while ensuring health for all. The economic case for investments in interventions addressing environmental, climatic and occupational risk factors comprises a heath economic argument, as well as economic co-benefits within and across the environment, climate and labour sectors.

The World Health Organization and its Department of Environment, Climate Change and Health (ECH) look to promote a healthier environment, intensify primary action and influence public policies in all sectors, to address the root causes of environmental threats to health. ECH develops and promotes preventive policies and interventions based on an in-depth, scientific analysis of the evidence base for environmental determinants of human health. ECH is guided and mandated by the WHO Global Strategy on Health, Environment and Climate Change.

ECH has established a new and dedicated work stream of environmental health economic evaluation and analysis. This work stream seeks to develop a standard approach for conducting and reporting environmental health economic evaluation and analysis, produce a set of official environmental health economic estimates, and deliver a case for global investment in environment, climate change and health. This will include the conduct of global cost-benefit analyses of selected intervention packages, such as improved infrastructure for water, sanitation and hygiene; cleaner cooking stoves; phase out of selected fossil fuel subsidies; and regulation of working time to healthy limits.

Functions of the Technical Advisory Group on Economics for Environment, Climate Change and Health

  • To provide independent evaluation of the scientific technical and strategic aspects of the economics for environment, climate change and health, with a focus on the global Investment Case for Health, Environment and Climate Change;
  • To recommend priority topics related to economic evaluation and analysis for environment, climate change and health for consideration within the Organization and/or relevant technical unit;
  • To advise WHO on its economic evaluation and analysis for environment, climate change and health, especially as it relates to the global Investment Case for Health, Environment and Climate Change; and
  • To review and make recommendations to WHO on disease and intervention priorities, economic models and estimates (e.g., of cost of inaction, intervention costs, economic benefits, and cost-benefits), and economic arguments for interventions addressing environmental, climatic and occupational risk factors.

Operations of the Technical Advisory Group on Economics for Environment, Climate Change and Health

The Technical Advisory Group on Economics for Environment, Climate Change and Health. All AG meetings will be held virtually, but interim teleconferences with selected group members may also be required. The WHO Secretariat will share products with the AG by email for the members to review and provide advice in a timely manner (to be specified for each task). The working language of the group will be English.

Who can express interest?

The Technical Advisory Group on Economics for Environment, Climate Change and Health  will be multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to health and environmental economics. Approximately 15 individual experts may be selected.

WHO welcomes expressions of interest from scientists, healthcare professionals and healthcare regulators with expertise in the following areas:

  • health economics
  • environmental economics
  • climate change economics
  • labour economics
  • public financing
  • investment cases
  • cost-benefit analysis

Submitting your expression of interest

To register your interest in being considered for the Technical Advisory Group on Economics for Environment, Climate Change and Health , please submit the following documents by 29 March 2023 to pegaf@who.int using the subject line “Expression of interest for the Technical Advisory Group on Economics for Environment, Climate Change and Health“:

  • A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore do not use the letterhead or other identification of your employer);
  • Your curriculum vitae; and
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed. 

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of a AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or  to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account  the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of a AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest , to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing TAG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to pegaf@who.int well before the applicable deadline.

Deadline: 29 March 2023

OFFICIAL LINK

March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Public Health Update | Up to date public health info & Opportunities
Call for Proposal, EOI & RFPDrug and MedicineNotice

WHO 2023 data call is now open for antibacterials in the preclinical development pipeline

by Public Health Update March 12, 2023
written by Public Health Update

Developers of traditional and nontraditional agents intended against pathogens on the WHO BPPL and against other medically important pathogens are encouraged to submit their data

Introduction 

In January 2020 WHO published its first global analyses of the preclinical antibacterial pipeline, based on publicly available data. The data were primarily gathered through an open data call, with planned annual updates.

The antibacterial pre-clinical pipeline was reviewed again in 2021, and the updates were published in 2022. The updated data are available on the open source WHO Global Health R&D Observatory, and the full updated analyses was also published in the WHO report entitled:  2021 antibacterial agents in clinical and preclinical development: an overview and analysis. 

WHO 2023 data call for antibacterial agents in preclinical development pipeline aims to collect data on traditional and non-traditional antibacterial agents candidates intended against the WHO bacterial priority pathogens (WHO BPPL) and other antibacterial resistant pathogens of public health importance.

This year WHO is collecting information on antimicrobials relevant for AMR including other medically important resistant pathogens, that are not included in the 2017 WHO BPPL.

The 2023 preclinical data updates and analyses will feed into the open WHO source Global Health R&D Observatory and will be available for all stakeholders.

We would like to thank those who have responded to previous WHO data calls and encourage your participation in this year’s data call. 

Scope and definitions

For this data call/review, the term “preclinical products” refers to all products* from lead-optimization (post hit expansion), preclinical candidate, to formal CTA/IND enabling studies prior to the commencement of human testing.  

  • Lead optimization: iterative in vitro and in vivo screens of lead compounds to generate suitable pharmacological, safety and pharmacokinetic profiles of one or more candidates to progress into preclinical development.   
  • Preclinical candidate: a lead compound, or a shortlist of compounds that are being actively compared, that have been evaluated in initial toxicology tests and demonstrates the required safety profile which when combined with a suitable understanding of pharmacological efficacy warrants advancement. 
  • CTA/IND-enabling studies: studies including detailed ADME (absorption, distribution, metabolism, and excretion) studies and GLP (good laboratory practice) toxicology, as well as formulation and manufacturing development necessary to obtain the permission from regulatory authorities to begin human clinical testing. 


* Note: For any given program, if a medicinal chemistry backup program is ongoing in parallel with advancement of a lead compound(s) in the same chemical series then the development phase of the most advanced compound being actively studied should be recorded. Inclusion criteria and scope of WHO analysis for antibacterial agents in preclinical development

Products that are active against WHO bacterial priority pathogens, M. tuberculosis, C. difficile or other medically important bacterial pathogens should be included in the preclinical pipeline analysis.  These include: 

  1. Directly and indirectly acting small molecule antibacterial agents (including antimycobacterial drugs)
  2. Anti-virulence agents and biofilm disruptors 
  3. Potentiators or enablers that improve activity of existing products (e.g., resistance modulating agents, BLI, penetration enablers, efflux inhibitors)
  4. Large molecules (natural products, e.g., antimicrobial peptides, biologics, e.g., antibodies, bacteriophages and bacteriophages derived products)
  5. Microbiome modifying agents
  6. Immunomodulators
  7. Repurposed non-antibiotics
  8. Repurposed from animal to human use antibiotics
  9. De-colonization agents
  10. Combination therapies

Companies, institutions, and individuals are invited to submit data on their products that are in the preclinical pipeline that fulfil the above inclusion criteria. Data submitted should be non-confidential and will be made available publicly on the WHO Global Health R&D Observatory. 

Exclusion criteria (for antibacterial agents in preclinical development)

Products excluded from this analysis are diagnostics, vaccines, antivirals, antiparasitics and antifungals as they are covered through other WHO programmes/publications.

In addition, wound care products, unspecific supportive treatments, topical or locally administered products targeting mild skin or local infections, medical devices, industrial or animal use are also not included. 

Data collection form links

WHO 2023 survey on antibacterial agents in the preclinical developmental pipeline.

Opening date: 6 March 2023 at 12:00 Geneva time

Closing date: 17 April 2023 at 23:30 Geneva time

Official link

March 12, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Newer Posts
Older Posts

Search

Follow Us

Facebook Twitter Instagram Pinterest Linkedin Youtube

Categories

  • Abstracts (25)
  • Activities (91)
  • Adolescent Sexual and Reproductive Health (ASRH) (25)
  • Advice & Tips (3)
  • African Region (5)
  • AI and Health (1)
  • Annual Meeting (6)
  • Antimicrobial Resistance (AMR) (21)
  • Award (19)
  • Awards (16)
  • Books (9)
  • Call for Proposal, EOI & RFP (103)
  • Call for Research Participants (8)
  • Clinical Doctor Jobs (6)
  • Communicable Diseases (107)
  • Competition (20)
  • Conference (128)
  • Consultant (1)
  • Courses (205)
  • Dashboard (2)
  • Digital Health & Health Informatics (10)
  • Drug and Medicine (18)
  • Eastern Mediterranean Region (3)
  • Education (15)
  • Environment (3)
  • Environmental Health & Climate Change (47)
  • European Region (42)
  • Exchange Program (1)
  • Fact Sheet (117)
  • FCHVs (1)
  • Fellowships, Studentship & Scholarships (168)
  • Financial Aid (13)
  • Form Formats (2)
  • Fully funded (22)
  • Global Health News (433)
  • Grants and Funding Opportunities (193)
  • Guest Post (44)
  • Health Assistant Jobs (1)
  • Health Equity (7)
  • Health Financing and Economics (24)
  • Health in Data (115)
  • Health Insurance (5)
  • Health Jobs (52)
  • Health Literacy, Health Education & Promotion (49)
  • Health Organization Profile (42)
  • Health Systems (83)
  • Human Resource for Health (33)
  • Humanitarian Health & Emergency Response (44)
  • Hypertension (5)
  • Implementation Research (48)
  • International Health (3)
  • International Jobs & Opportunities (373)
  • International Plan, Policy & Guidelines (210)
  • Internships (4)
  • Jobs Vacancies (56)
  • Journals (8)
  • Life Style & Public Health Nutrition (39)
  • Live (10)
  • Master's Degree (48)
  • Maternal, Newborn and Child Health (88)
  • Mentorship Program (2)
  • Miscellaneous (16)
  • National Health News (157)
  • National Plan, Policy & Guidelines (468)
  • Neglected Tropical Diseases (NTDs) (51)
  • Non- Communicable Diseases (NCDs) (120)
  • Notice (103)
  • Nursing Jobs (6)
  • Nutritionist Jobs (1)
  • One Health (17)
  • Online & Distance Learning (22)
  • Online Courses (90)
  • Op-Ed Article (3)
  • Opportunities by Region (83)
  • Outbreak News (213)
  • Partially funded (6)
  • PCL Health Science Jobs (3)
  • PH Important Day (533)
  • Pharmacist Jobs (3)
  • PhD (54)
  • Photos (5)
  • Planetary Health (4)
  • PostDoc (14)
  • Presentation Slides (26)
  • Primary Health Care (25)
  • Provincial Plan, Policies and Guidelines (14)
  • Public Health (1,281)
  • Public Health Epidemiology & Biostatistics (13)
  • Public Health Events (306)
  • Public Health Information (20)
  • Public Health Innovation (9)
  • Public Health Jobs (52)
  • Public Health News (552)
  • Public Health Notes (120)
  • Public Health Opportunities (507)
  • Public Health Opportunity (491)
  • Public Health Programs (108)
  • Public Health Seminar (2)
  • Public Health Tools (1)
  • Public Health Update (561)
  • Quality Improvement & Infection Prevention (20)
  • Region of America (8)
  • Reports (184)
  • Research & Project Grants (39)
  • Research & Project Grants (32)
  • Research & Publication (647)
  • Research Articles (10)
  • Road Traffic Accidents (RTA) (9)
  • School of Public Health (60)
  • Self funded (2)
  • South-East Asia Region (26)
  • Success Stories (17)
  • Summer and Winter Courses (40)
  • Summer Courses (28)
  • Sustainable Development Goals (SDGs) (14)
  • Syllabus (61)
  • Symposium (9)
  • Tobacco Control (35)
  • Training (40)
  • Travel Grants (15)
  • Trick, Technique & Skills (8)
  • Uncategorized (3)
  • Undergraduate Degree (7)
  • Universal Health Coverage (36)
  • Universities (29)
  • Universities & School of Public Health (58)
  • Vacancy Announcement (26)
  • Vaccine Preventable Diseases (40)
  • Vector-Borne Diseases(VBDs) (30)
  • Videos (3)
  • View Points (1)
  • Webinar (4)
  • Western Pacific Region (13)
  • Workshop (18)
  • World News (116)
Post New Jobs: Vacancy Announcement Service
Post New Jobs: Vacancy Announcement Service

Public Health Update (Sagun’s Blog) is a popular public health portal in Nepal. Thousands of health professionals are connected with Public Health Update to get up-to-date public health updates, search for jobs, and explore opportunities.
#1 Public Health Blog for sharing Job opportunities and updates in Nepal

”Public Health Information For All”
– – Sagun Paudel, Founder

  • HOT JOBS
    • Public Health Jobs
    • Medical Doctor Jobs
    • Nursing Jobs
    • Health Assistant Jobs
    • Pharmacist Jobs
    • NGOs Jobs
    • Government Jobs
  • Top Categories
    • National Plan, Policy & Guidelines Top
    • Public Health Calendar
    • Fellowships & Scholarships
    • Health Systems
    • Health Organization Profiles
    • International Jobs & Opportunities
    • Public Health Opportunity

PUBLIC HEALTH INITIATIVE

    • Submit your Vacancies New
    • Partnership Opportunities

Contact: blog.publichealthupdate@gmail.com

https://wa.me/+9779856036932

Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2024. Contact us. 

Facebook Twitter Instagram Youtube Envelope
Public Health Update
  • Home
  • Public Health
    • Home 1
      • Adolescent Sexual and Reproductive Health (ASRH)
      • Antimicrobial Resistance (AMR)
      • Communicable Diseases
      • Digital Health & Health Informatics
      • Environmental Health & Climate Change
      • Health Financing and Economics
      • Health Equity
    • Home 2
      • Health Literacy, Health Education & Promotion
      • Human Resource for Health
      • Humanitarian Health & Emergency Response
      • Implementation Research
      • International Health
      • Life Style & Public Health Nutrition
      • Maternal, Newborn and Child Health
    • Home 3
      • Neglected Tropical Diseases (NTDs)
      • Non- Communicable Diseases (NCDs)
      • One Health
      • Planetary Health
      • Public Health Epidemiology & Biostatistics
      • Primary Health Care
      • Quality Improvement & Infection Prevention
    • Home 4
      • Road Traffic Accidents (RTA)
      • Sustainable Development Goals (SDGs)
      • Tobacco Control
      • Universal Health Coverage
      • Vaccine Preventable Diseases
      • Vector-Borne Diseases(VBDs)
      • Notices
  • Public Health Update
    • Home 1
      • Public Health News
      • Global Health News
      • Outbreak News
      • National Health News
      • COVID-19
    • Home 2
      • Fact Sheet
      • Health in Data
      • PH Important Day
      • Public Health Events
      • Public Health Programs
    • Home 3
      • Health Systems
      • Health Insurance
      • Health Organization Profile
      • Success Stories
      • Public Health Innovation
  • Public Health Opportunities
    • Fully funded
    • Travel Grants
    • Grants and Funding Opportunities
    • Opportunities by Region
    • International Jobs & Opportunities
    • Research & Project Grants
    • Fellowships, Studentship & Scholarships
    • Conference
  • Jobs
    • Home 1
      • Health Jobs
      • Public Health Jobs
      • Clinical doctor Jobs
      • Health Assistant Jobs
      • Nursing Jobs
      • PCL Health Science Jobs
    • Home 2
      • Dental Jobs
      • Pharmacist Jobs
      • TSLC (Health Jobs)
      • Laboratory Jobs
      • Nutritionist Jobs
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Books
    • Research Articles
  • School of Public Health
    • Home 1
      • Courses
      • Master’s Degree
      • Undergraduate Degree
      • PhD
    • Home 2
      • Universities
      • Syllabus
      • Public Health Notes
      • Mentorship Program
      • Startup Project
    • Home
      • Summer and Winter Courses
      • Summer Courses
      • Online Courses
      • Workshop
      • Training
Public Health Update
  • Home
  • Public Health
    • Home 1
      • Adolescent Sexual and Reproductive Health (ASRH)
      • Antimicrobial Resistance (AMR)
      • Communicable Diseases
      • Digital Health & Health Informatics
      • Environmental Health & Climate Change
      • Health Financing and Economics
      • Health Equity
    • Home 2
      • Health Literacy, Health Education & Promotion
      • Human Resource for Health
      • Humanitarian Health & Emergency Response
      • Implementation Research
      • International Health
      • Life Style & Public Health Nutrition
      • Maternal, Newborn and Child Health
    • Home 3
      • Neglected Tropical Diseases (NTDs)
      • Non- Communicable Diseases (NCDs)
      • One Health
      • Planetary Health
      • Public Health Epidemiology & Biostatistics
      • Primary Health Care
      • Quality Improvement & Infection Prevention
    • Home 4
      • Road Traffic Accidents (RTA)
      • Sustainable Development Goals (SDGs)
      • Tobacco Control
      • Universal Health Coverage
      • Vaccine Preventable Diseases
      • Vector-Borne Diseases(VBDs)
      • Notices
  • Public Health Update
    • Home 1
      • Public Health News
      • Global Health News
      • Outbreak News
      • National Health News
      • COVID-19
    • Home 2
      • Fact Sheet
      • Health in Data
      • PH Important Day
      • Public Health Events
      • Public Health Programs
    • Home 3
      • Health Systems
      • Health Insurance
      • Health Organization Profile
      • Success Stories
      • Public Health Innovation
  • Public Health Opportunities
    • Fully funded
    • Travel Grants
    • Grants and Funding Opportunities
    • Opportunities by Region
    • International Jobs & Opportunities
    • Research & Project Grants
    • Fellowships, Studentship & Scholarships
    • Conference
  • Jobs
    • Home 1
      • Health Jobs
      • Public Health Jobs
      • Clinical doctor Jobs
      • Health Assistant Jobs
      • Nursing Jobs
      • PCL Health Science Jobs
    • Home 2
      • Dental Jobs
      • Pharmacist Jobs
      • TSLC (Health Jobs)
      • Laboratory Jobs
      • Nutritionist Jobs
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Books
    • Research Articles
  • School of Public Health
    • Home 1
      • Courses
      • Master’s Degree
      • Undergraduate Degree
      • PhD
    • Home 2
      • Universities
      • Syllabus
      • Public Health Notes
      • Mentorship Program
      • Startup Project
    • Home
      • Summer and Winter Courses
      • Summer Courses
      • Online Courses
      • Workshop
      • Training
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023